Study Of GW679769 In Major Depressive Disorder
NCT00102492
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
356
Enrollment
INDUSTRY
Sponsor class
Conditions
Depressive Disorder, Major
Major Depressive Disorder (MDD)
Interventions
DRUG:
GW679769
Sponsor
GlaxoSmithKline